vs

Side-by-side financial comparison of Arcellx, Inc. (ACLX) and FRP HOLDINGS, INC. (FRPH). Click either name above to swap in a different company.

FRP HOLDINGS, INC. is the larger business by last-quarter revenue ($10.9M vs $8.1M, roughly 1.3× Arcellx, Inc.). FRP HOLDINGS, INC. runs the higher net margin — 1.3% vs -766.0%, a 767.3% gap on every dollar of revenue. On growth, FRP HOLDINGS, INC. posted the faster year-over-year revenue change (3.6% vs -79.3%). FRP HOLDINGS, INC. produced more free cash flow last quarter ($-21.5M vs $-63.9M). Over the past eight quarters, FRP HOLDINGS, INC.'s revenue compounded faster (3.8% CAGR vs -24.6%).

Arcellx, Inc. is a clinical-stage biotechnology company that develops innovative chimeric antigen receptor T (CAR-T) cell therapies for treating hard-to-treat cancers including hematologic malignancies and solid tumors. Its core pipeline targets unmet oncology medical needs, serving global patient populations and partnering with life sciences stakeholders.

FRP Advisory is a business advisory firm based in the United Kingdom, providing restructuring, corporate finance, debt advisory, forensic accounting and financial advisory and is one of the UK’s largest specialists in the area of corporate restructuring.

ACLX vs FRPH — Head-to-Head

Bigger by revenue
FRPH
FRPH
1.3× larger
FRPH
$10.9M
$8.1M
ACLX
Growing faster (revenue YoY)
FRPH
FRPH
+82.9% gap
FRPH
3.6%
-79.3%
ACLX
Higher net margin
FRPH
FRPH
767.3% more per $
FRPH
1.3%
-766.0%
ACLX
More free cash flow
FRPH
FRPH
$42.5M more FCF
FRPH
$-21.5M
$-63.9M
ACLX
Faster 2-yr revenue CAGR
FRPH
FRPH
Annualised
FRPH
3.8%
-24.6%
ACLX

Income Statement — Q1 FY2025 vs Q4 FY2025

Metric
ACLX
ACLX
FRPH
FRPH
Revenue
$8.1M
$10.9M
Net Profit
$-62.3M
$139.0K
Gross Margin
Operating Margin
-847.6%
15.4%
Net Margin
-766.0%
1.3%
Revenue YoY
-79.3%
3.6%
Net Profit YoY
-765.1%
-91.8%
EPS (diluted)
$-1.13
$0.03

Green = leading value per metric. Periods may differ when fiscal calendars don't align.

8-Quarter Revenue & Profit Trend

Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.

Revenue
ACLX
ACLX
FRPH
FRPH
Q4 25
$10.9M
Q3 25
$10.8M
Q2 25
$10.8M
Q1 25
$8.1M
$10.3M
Q4 24
$15.3M
$10.5M
Q3 24
$26.0M
$10.6M
Q2 24
$27.4M
$10.5M
Q1 24
$39.3M
$10.1M
Net Profit
ACLX
ACLX
FRPH
FRPH
Q4 25
$139.0K
Q3 25
$662.0K
Q2 25
$578.0K
Q1 25
$-62.3M
$1.7M
Q4 24
$-47.1M
$1.7M
Q3 24
$-25.9M
$1.4M
Q2 24
$-27.2M
$2.0M
Q1 24
$-7.2M
$1.3M
Operating Margin
ACLX
ACLX
FRPH
FRPH
Q4 25
15.4%
Q3 25
12.6%
Q2 25
15.3%
Q1 25
-847.6%
22.6%
Q4 24
-348.2%
27.7%
Q3 24
-129.1%
29.0%
Q2 24
-127.8%
26.9%
Q1 24
-40.3%
28.4%
Net Margin
ACLX
ACLX
FRPH
FRPH
Q4 25
1.3%
Q3 25
6.1%
Q2 25
5.3%
Q1 25
-766.0%
16.6%
Q4 24
-308.4%
16.0%
Q3 24
-99.4%
12.8%
Q2 24
-99.3%
19.5%
Q1 24
-18.3%
12.8%
EPS (diluted)
ACLX
ACLX
FRPH
FRPH
Q4 25
$0.03
Q3 25
$0.03
Q2 25
$0.03
Q1 25
$-1.13
$0.09
Q4 24
$-0.87
$0.09
Q3 24
$-0.48
$0.07
Q2 24
$-0.51
$0.11
Q1 24
$-0.14
$0.07

Balance Sheet & Financial Strength

Snapshot of each company's liquidity, leverage and book value from the latest quarter.

Metric
ACLX
ACLX
FRPH
FRPH
Cash + ST InvestmentsLiquidity on hand
$543.3M
Total DebtLower is stronger
$192.6M
Stockholders' EquityBook value
$416.9M
$428.5M
Total Assets
$648.1M
$735.1M
Debt / EquityLower = less leverage
0.45×

8-quarter trend — quarters aligned by calendar period.

Cash + ST Investments
ACLX
ACLX
FRPH
FRPH
Q4 25
Q3 25
$134.9M
Q2 25
$153.2M
Q1 25
$543.3M
$142.9M
Q4 24
$587.4M
$148.6M
Q3 24
$574.3M
$144.7M
Q2 24
$516.7M
$156.9M
Q1 24
$573.9M
$152.5M
Total Debt
ACLX
ACLX
FRPH
FRPH
Q4 25
$192.6M
Q3 25
$185.3M
Q2 25
$180.4M
Q1 25
$178.3M
Q4 24
$178.9M
Q3 24
$178.8M
Q2 24
$178.8M
Q1 24
$178.7M
Stockholders' Equity
ACLX
ACLX
FRPH
FRPH
Q4 25
$428.5M
Q3 25
$427.7M
Q2 25
$426.7M
Q1 25
$416.9M
$425.2M
Q4 24
$454.8M
$423.1M
Q3 24
$483.0M
$420.9M
Q2 24
$487.2M
$419.1M
Q1 24
$496.6M
$416.1M
Total Assets
ACLX
ACLX
FRPH
FRPH
Q4 25
$735.1M
Q3 25
$731.3M
Q2 25
$722.8M
Q1 25
$648.1M
$717.1M
Q4 24
$711.3M
$728.5M
Q3 24
$764.9M
$726.9M
Q2 24
$734.3M
$711.9M
Q1 24
$779.7M
$705.7M
Debt / Equity
ACLX
ACLX
FRPH
FRPH
Q4 25
0.45×
Q3 25
0.43×
Q2 25
0.42×
Q1 25
0.42×
Q4 24
0.42×
Q3 24
0.42×
Q2 24
0.43×
Q1 24
0.43×

Cash Flow & Capital Efficiency

How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.

Metric
ACLX
ACLX
FRPH
FRPH
Operating Cash FlowLast quarter
$-63.1M
$29.7M
Free Cash FlowOCF − Capex
$-63.9M
$-21.5M
FCF MarginFCF / Revenue
-786.4%
-196.6%
Capex IntensityCapex / Revenue
9.6%
468.5%
Cash ConversionOCF / Net Profit
213.50×
TTM Free Cash FlowTrailing 4 quarters
$-122.5M
$-34.4M

8-quarter trend — quarters aligned by calendar period.

Operating Cash Flow
ACLX
ACLX
FRPH
FRPH
Q4 25
$29.7M
Q3 25
$8.1M
Q2 25
$8.7M
Q1 25
$-63.1M
$4.5M
Q4 24
$-46.0M
$29.0M
Q3 24
$30.7M
$6.3M
Q2 24
$-36.2M
$12.2M
Q1 24
$-31.9M
$2.9M
Free Cash Flow
ACLX
ACLX
FRPH
FRPH
Q4 25
$-21.5M
Q3 25
$-16.9M
Q2 25
$2.6M
Q1 25
$-63.9M
$1.4M
Q4 24
$-47.5M
$-22.2M
Q3 24
$28.4M
$-28.2M
Q2 24
$-39.5M
$5.9M
Q1 24
$-38.3M
$-3.3M
FCF Margin
ACLX
ACLX
FRPH
FRPH
Q4 25
-196.6%
Q3 25
-157.0%
Q2 25
24.0%
Q1 25
-786.4%
13.6%
Q4 24
-311.3%
-210.9%
Q3 24
109.2%
-265.7%
Q2 24
-144.1%
56.0%
Q1 24
-97.7%
-32.6%
Capex Intensity
ACLX
ACLX
FRPH
FRPH
Q4 25
468.5%
Q3 25
232.0%
Q2 25
55.9%
Q1 25
9.6%
30.1%
Q4 24
9.8%
486.1%
Q3 24
8.8%
325.1%
Q2 24
11.7%
60.3%
Q1 24
16.4%
61.2%
Cash Conversion
ACLX
ACLX
FRPH
FRPH
Q4 25
213.50×
Q3 25
12.21×
Q2 25
15.00×
Q1 25
2.63×
Q4 24
17.18×
Q3 24
4.65×
Q2 24
5.96×
Q1 24
2.23×

Financial Flow Comparison

Revenue → gross profit → operating profit → net profit for each company.

Revenue Breakdown by Segment

ACLX
ACLX

Segment breakdown not available.

FRPH
FRPH

Other$5.6M51%
Multifamily Segment$5.3M49%

Related Comparisons